| Trade Names | |
| Synonyms | |
| Status | |
| Molecule Category | Free-form |
| ATC | L02BB04 |
| UNII | 93T0T9GKNU |
| InChI Key | WXCXUHSOUPDCQV-UHFFFAOYSA-N |
|---|---|
| Smiles | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H16F4N4O2S |
| Molecular Weight | 464.44 |
| AlogP | 3.99 |
| Hydrogen Bond Acceptor | 4.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 76.44 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 32.0 |
| Mechanism of Action | Action | Reference |
|---|---|---|
| Androgen Receptor antagonist | ANTAGONIST | Expert |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | 130 | - | - | - | |
|
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 3
Nuclear hormone receptor subfamily 3 group C
Nuclear hormone receptor subfamily 3 group C member 4
|
49-915 | 14-646.9 | - | 17-86 | 20-95 |
|
Protein: Androgen Receptor Description: Androgen receptor Organism : Homo sapiens P10275 ENSG00000169083 |
||||
| Resources | Reference |
|---|---|
| ChEBI | 68534 |
| ChEMBL | CHEMBL1082407 |
| DrugBank | DB08899 |
| DrugCentral | 4628 |
| FDA SRS | 93T0T9GKNU |
| Guide to Pharmacology | 6812 |
| KEGG | D10218 |
| PubChem | 15951529 |
| SureChEMBL | SCHEMBL189749 |
| ZINC | ZINC000034806477 |